{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T16:53:38Z","timestamp":1790787218735,"version":"4.1.0"},"reference-count":82,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,10,22]],"date-time":"2019-10-22T00:00:00Z","timestamp":1571702400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"uropean Union's Seventh Framework Programme"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience & Biobehavioral Reviews"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.neubiorev.2019.09.023","type":"journal-article","created":{"date-parts":[[2019,9,20]],"date-time":"2019-09-20T11:18:16Z","timestamp":1568978296000},"page":"945-968","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":103,"special_numbering":"C","title":["Neurological and psychiatric adverse effects of long-term methylphenidate treatment in ADHD: A map of the current evidence"],"prefix":"10.1016","volume":"107","author":[{"given":"Helga","family":"Krinzinger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte L","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madeleine J","family":"Groom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed T","family":"Ansari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Banaschewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan K","family":"Buitelaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Carucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Coghill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Danckaerts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf W","family":"Dittmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Falissard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Garas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah K","family":"Inglis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna","family":"Kovshoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Puja","family":"Kochhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne","family":"McCarthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Nagy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antje","family":"Neubert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kapil","family":"Sayal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edmund","family":"Sonuga-Barke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian C K","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Zuddas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Hollis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerstin","family":"Konrad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth B","family":"Liddle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neubiorev.2019.09.023_bib0005","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1089\/cap.2008.0146","article-title":"Predictive factors for persistent use and compliance of immediate-release methylphenidate: a 36-Month naturalistic study","volume":"19","author":"Atzori","year":"2009","journal-title":"J. Child Adolesc. Psychopharmacol."},{"key":"10.1016\/j.neubiorev.2019.09.023_bib0010","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1542\/peds.2008-3347","article-title":"Do stimulants protect against psychiatric disorders in youth with ADHD? A 10-year follow-up study","volume":"124","author":"Biederman","year":"2009","journal-title":"Pediatrics"},{"key":"10.1016\/j.neubiorev.2019.09.023_bib0015","doi-asserted-by":"crossref","first-page":"289","DOI":"10.2217\/cpr.14.26","article-title":"Reintroduction of stimulant treatment for patients with ADHD, after stimulant-related psychosis","volume":"11","author":"Chammas","year":"2014","journal-title":"Clin. Pract."},{"key":"10.1016\/j.neubiorev.2019.09.023_bib0020","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/j.biopsych.2016.02.018","article-title":"Medication for Attention-Deficit\/Hyperactivity disorder and risk for depression: a nationwide longitudinal cohort study","volume":"80","author":"Chang","year":"2016","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2019.09.023_bib0025","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1111\/jcpp.12164","article-title":"Stimulant ADHD medication and risk for substance abuse","volume":"55","author":"Chang","year":"2014","journal-title":"J. Child Psychol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2019.09.023_bib0030","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1177\/070674379904400810","article-title":"Psychotic side effects of psychostimulants: a 5-year review","volume":"44","author":"Cherland","year":"1999","journal-title":"Can. J. Psychiatry Rev. Can. Psychiatr."},{"key":"10.1016\/j.neubiorev.2019.09.023_bib0035","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1097\/00004583-199910000-00018","article-title":"Sleep problems in children with attention-deficit\/hyperactivity disorder: impact of subtype, comorbidity, and stimulant medication","volume":"38","author":"Corkum","year":"1999","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.neubiorev.2019.09.023_bib0040","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1007\/s40263-015-0266-7","article-title":"Safety of methylphenidate and Atomoxetine in children with Attention-Deficit\/Hyperactivity disorder (ADHD): data from the italian national ADHD registry","volume":"29","author":"Cortese","year":"2015","journal-title":"CNS Drugs"},{"key":"10.1016\/j.neubiorev.2019.09.023_bib0045","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1097\/JCP.0000000000000917","article-title":"Long-term tolerability and safety of pharmacological treatment of adult Attention-Deficit\/Hyperactivity disorder: a 6-Year prospective naturalistic study","volume":"38","author":"Edvinsson","year":"2018","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.neubiorev.2019.09.023_bib0050","first-page":"410","article-title":"Psychotic symptoms associated with switching from OROS methylphenidate to modified-release methylphenidate. ANADOLU PSIKIYATRI Derg.-Anatol","volume":"18","author":"Ekinci","year":"2017","journal-title":"J. Psychiatry"},{"key":"10.1016\/j.neubiorev.2019.09.023_bib0055","doi-asserted-by":"crossref","first-page":"316","DOI":"10.5455\/bcp.20151223093022","article-title":"Suicide attempt with high dose long acting methylphenidate ingestion: a case presentation","volume":"26","author":"Erkuran","year":"2016","journal-title":"Klin. Psikofarmakol. Bul."},{"key":"10.1016\/j.neubiorev.2019.09.023_bib0060","doi-asserted-by":"crossref","first-page":"384","DOI":"10.5455\/bcp.20140709015737","article-title":"Long-acting methylphenidate toxicity: a case report Uzun etkili metilfenidat toksisitesi: Bir olgu sunumu","volume":"24","author":"Eryilmaz","year":"2014","journal-title":"Klin. Psikofarmakol. Bul."},{"key":"10.1016\/j.neubiorev.2019.09.023_bib0065","series-title":"Methylphenidate - Article 31 Referral - Annex II","author":"European Medicines Agency","year":"2007"},{"key":"10.1016\/j.neubiorev.2019.09.023_bib0070","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1111\/epi.12399","article-title":"Methylphenidate treatment of attention deficit hyperactivity disorder in young people with learning disability and difficult-to-treat epilepsy: evidence of clinical benefit","volume":"54","author":"Fosi","year":"2013","journal-title":"Epilepsia"},{"key":"10.1016\/j.neubiorev.2019.09.023_bib0075","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1111\/j.1469-8749.2000.tb00346.x","article-title":"An international perspective on Tourette syndrome: selected findings from 3,500 individuals in 22 countries","volume":"42","author":"Freeman","year":"2000","journal-title":"Dev. Med. Child Neurol."},{"key":"10.1016\/j.neubiorev.2019.09.023_bib0080","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1001\/archpsyc.56.4.330","article-title":"Long-term methylphenidate therapy in children with comorbid attention-deficit hyperactivity disorder and chronic multiple tic disorder","volume":"56","author":"Gadow","year":"1999","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neubiorev.2019.09.023_bib0085","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1097\/00004583-199806000-00006","article-title":"Intranasal abuse of prescribed methylphenidate","volume":"37","author":"Garland","year":"1998","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.neubiorev.2019.09.023_bib0090","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1093\/sleep\/32.5.671","article-title":"Sleep problems and disorders among adolescents with persistent and subthreshold Attention-deficit\/Hyperactivity disorders","volume":"32","author":"Gau","year":"2009","journal-title":"Sleep"},{"key":"10.1016\/j.neubiorev.2019.09.023_bib0095","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1097\/00004583-200105000-00010","article-title":"Psychostimulants in preschool children with attention-deficit\/hyperactivity disorder: clinical evidence from a developmental disorders institution","volume":"40","author":"Ghuman","year":"2001","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.neubiorev.2019.09.023_bib0100","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1097\/JCP.0000000000000395","article-title":"Long-term treatment outcome in adult male prisoners with Attention-Deficit\/Hyperactivity disorder: three-year naturalistic follow-up of a 52-Week methylphenidate trial","volume":"35","author":"Ginsberg","year":"2015","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.neubiorev.2019.09.023_bib0105","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/S0002-7138(09)60486-6","article-title":"Abuse of prescribed stimulant medication by a 13-year-old hyperactive boy","volume":"18","author":"Goyer","year":"1979","journal-title":"J. Am. Acad. Child Psychiatry"},{"key":"10.1016\/j.neubiorev.2019.09.023_bib0110","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1212\/01.WNL.0000134656.93147.F1","article-title":"Hallucinations during methylphenidate therapy","volume":"63","author":"Gross-Tsur","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.neubiorev.2019.09.023_bib0115","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1177\/08830738030180020601","article-title":"Use of methylphenidate for attention-deficit hyperactivity disorder in patients with epilepsy or electroencephalographic abnormalities","volume":"18","author":"Gucuyener","year":"2003","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.neubiorev.2019.09.023_bib0120","first-page":"30","article-title":"Adjunctive methylphenidate in the treatment of bulimia nervosa Co-occurring with bipolar disorder and substance dependence","volume":"10","author":"Guerdjikova","year":"2013","journal-title":"Innov. Clin. Neurosci."},{"key":"10.1016\/j.neubiorev.2019.09.023_bib0125","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1177\/1087054712468051","article-title":"Do stimulants reduce the risk for alcohol and substance use in youth with ADHD? A secondary analysis of a prospective, 24-Month open-label study of osmotic-release methylphenidate","volume":"21","author":"Hammerness","year":"2017","journal-title":"J. Atten. Disord."},{"key":"10.1016\/j.neubiorev.2019.09.023_bib0130","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s12402-015-0177-y","article-title":"Attention-deficit\/hyperactivity disorder under Treatment Outcomes Research (AUTOR): a European observational study in pediatric subjects","volume":"7","author":"Haynes","year":"2015","journal-title":"ADHD Atten. Deficit Hyperact. Disord."},{"key":"10.1016\/j.neubiorev.2019.09.023_bib0135","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1097\/01.chi.0000128796.84202.eb","article-title":"Academic achievement and emotional status of children with ADHD treated with long-term methylphenidate and multimodal psychosocial treatment","volume":"43","author":"Hechtman","year":"2004","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.neubiorev.2019.09.023_bib0140","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0002-7138(09)60501-X","article-title":"Young adult outcome of hyperactive children who received long-term stimulant treatment","volume":"23","author":"Hechtman","year":"1984","journal-title":"J. Am. Acad. Child Psychiatry"},{"key":"10.1016\/j.neubiorev.2019.09.023_bib0145","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0887-8994(00)00240-X","article-title":"Stimulant therapy and seizure risk in children with ADHD","volume":"24","author":"Hemmer","year":"2001","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.neubiorev.2019.09.023_bib0150","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s00787-016-0904-8","article-title":"Associations of attention-deficit\/hyperactivity and other childhood disorders with psychotic experiences and disorders in adolescence","volume":"26","author":"Hennig","year":"2017","journal-title":"Eur. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.neubiorev.2019.09.023_bib0155","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1111\/j.1365-2753.2008.01112.x","article-title":"Evidence mapping: illustrating an emerging methodology to improve evidence-based practice in youth mental health","volume":"16","author":"Hetrick","year":"2010","journal-title":"J. Eval. Clin. Pract."},{"key":"10.1016\/j.neubiorev.2019.09.023_bib0160","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1192\/bjp.2018.8","article-title":"Risk of suicide attempts in adolescents and young adults with attention-deficit hyperactivity disorder: a nationwide longitudinal study","volume":"212","author":"Huang","year":"2018","journal-title":"Br. J. Psychiatry J. Ment. Sci."},{"issue":"115","key":"10.1016\/j.neubiorev.2019.09.023_bib0165","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s00702-008-0872-3","article-title":"No increase in long-term risk for nicotine use disorders after treatment with methylphenidate in children with attention-deficit\/hyperactivity disorder (ADHD): evidence from a non-randomised retrospective study","volume":"1996","author":"Huss","year":"2008","journal-title":"J. Neural Transm. Vienna Austria"},{"key":"10.1016\/j.neubiorev.2019.09.023_bib0170","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1177\/070674370204700824","article-title":"Bupropion-methylphenidate combination and grand mal seizures","volume":"47","author":"Ickowicz","year":"2002","journal-title":"Can. J. Psychiatry - Rev. Can. Psychiatr."},{"key":"10.1016\/j.neubiorev.2019.09.023_bib0175","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1097\/JCP.0b013e31829839a4","article-title":"Intravenous abuse of methylphenidate","volume":"33","author":"Imbert","year":"2013","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.neubiorev.2019.09.023_bib0180","first-page":"773","article-title":"Case Study. Intranasal abuse of prescribed methylphenidate by an alcohol and drug abusing adolescent with ADHD","volume":"30","author":"Jaffe","year":"1991","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.neubiorev.2019.09.023_bib0185","doi-asserted-by":"crossref","first-page":"e1278","DOI":"10.4088\/JCP.14m09046","article-title":"Correlates of incident bipolar disorder in children and adolescents diagnosed with Attention-Deficit\/Hyperactivity disorder","author":"Jerrell","year":"2014","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.neubiorev.2019.09.023_bib0190","doi-asserted-by":"crossref","first-page":"399","DOI":"10.5455\/bcp.20150902042021","article-title":"Should we continue methylphenidate treatment despite orofacial or extremity dyskinesias? Klin. Psikofarmakol","volume":"25","author":"Kazanci","year":"2015","journal-title":"Bul. Bull. Clin. Psychopharmacol."},{"key":"10.1016\/j.neubiorev.2019.09.023_bib0195","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1176\/ajp.2006.163.4.716","article-title":"The prevalence and correlates of adult ADHD in the United States: results from the national comorbidity survey replication","volume":"163","author":"Kessler","year":"2006","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neubiorev.2019.09.023_bib0200","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0740-5472(84)90033-3","article-title":"Methylphenidate (Ritalin\u00ae) treatment of cocaine dependence\u2014a preliminary report","volume":"1","author":"Khantzian","year":"1984","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.neubiorev.2019.09.023_bib0205","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1055\/s-0035-1569361","article-title":"Cytogenetic effects of chronic methylphenidate treatment and chronic social stress in adults with Attention-Deficit\/Hyperactivity disorder","volume":"49","author":"Kittel-Schneider","year":"2016","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.neubiorev.2019.09.023_bib0210","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1097\/00008480-200204000-00013","article-title":"Abuse and toxicity of methylphenidate","volume":"14","author":"Klein-Schwartz","year":"2002","journal-title":"Curr. Opin. Pediatr."},{"key":"10.1016\/j.neubiorev.2019.09.023_bib0215","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/JCP.0000000000000668","article-title":"Effect of methylphenidate on emotional dysregulation in children with Attention-Deficit\/Hyperactivity disorder + oppositional defiant Disorder\/Conduct disorder","volume":"37","author":"Kutlu","year":"2017","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.neubiorev.2019.09.023_bib0220","doi-asserted-by":"crossref","first-page":"64","DOI":"10.5455\/bcp.20150908025240","article-title":"Aripiprazole treatment in a patient with schizophrenia and severe antipsychotic-induced parkinsonism following long-term use of methylphenidate: a case report -. Klin. Psikofarmakol","volume":"26","author":"Lee","year":"2016","journal-title":"Bul.-Bull. Clin. Psychopharmacol."},{"key":"10.1016\/j.neubiorev.2019.09.023_bib0225","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jad.2015.09.015","article-title":"Attention-deficit hyperactivity disorder, its treatment with medication and the probability of developing a depressive disorder: a nationwide population-based study in Taiwan.[Erratum appears in J Affect Disord. 2016 Jan 15;190:122]","volume":"189","author":"Lee","year":"2016","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.neubiorev.2019.09.023_bib0230","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ridd.2017.10.023","article-title":"Suicide risk reduction in youths with attention-deficit\/hyperactivity disorder prescribed methylphenidate: a Taiwan nationwide population-based cohort study","volume":"72","author":"Liang","year":"2018","journal-title":"Res. Dev. Disabil."},{"key":"10.1016\/j.neubiorev.2019.09.023_bib0235","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1001\/archpedi.1994.02170080089017","article-title":"Tics and dyskinesias associated with stimulant treatment in attention-deficit hyperactivity disorder","volume":"148","author":"Lipkin","year":"1994","journal-title":"Arch. Pediatr. Adolesc. Med."},{"key":"10.1016\/j.neubiorev.2019.09.023_bib0240","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1001\/jama.1971.03190080041008","article-title":"Methylphenidate hallucinosis","volume":"217","author":"Lucas","year":"1971","journal-title":"JAMA"},{"key":"10.1016\/j.neubiorev.2019.09.023_bib0245","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1001\/jamapsychiatry.2017.2183","article-title":"Association of risk of suicide attempts with methylphenidate treatment","volume":"74","author":"Man","year":"2017","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.neubiorev.2019.09.023_bib0250","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2016.216","article-title":"Methylphenidate and the risk of psychotic disorders and hallucinations in children and adolescents in a large health system","author":"Man","year":"2016","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.neubiorev.2019.09.023_bib0255","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1176\/appi.ajp.2008.07091465","article-title":"Age of methylphenidate treatment initiation in children with ADHD and later substance abuse: prospective follow-up into adulthood","volume":"165","author":"Mannuzza","year":"2008","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neubiorev.2019.09.023_bib0260","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s11920-015-0604-y","article-title":"Bipolar disorder and ADHD: comorbidity and diagnostic distinctions","volume":"17","author":"Marangoni","year":"2015","journal-title":"Curr. Psychiatry Rep."},{"key":"10.1016\/j.neubiorev.2019.09.023_bib0265","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s13643-016-0204-x","article-title":"What is an evidence map? A systematic review of published evidence maps and their definitions, methods, and products","volume":"5","author":"Miake-Lye","year":"2016","journal-title":"Syst. Rev."},{"key":"10.1016\/j.neubiorev.2019.09.023_bib0270","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1097\/CHI.0b013e31819c23d0","article-title":"The MTA at 8 Years: Prospective Follow-up of Children Treated for Combined-Type ADHD in a Multisite Study","volume":"48","author":"Molina","year":"2009","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.neubiorev.2019.09.023_bib0275","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1542\/peds.113.4.754","article-title":"National institute of mental health multimodal treatment study of ADHD follow-up: 24-Month outcomes of treatment strategies for Attention-Deficit\/Hyperactivity disorder","volume":"113","author":"MTA Cooperative Group","year":"2004","journal-title":"Pediatrics"},{"key":"10.1016\/j.neubiorev.2019.09.023_bib0280","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.33588\/rn.58S01.2014012","volume":"58","author":"Mulas","year":"2014","journal-title":"Rev. Neurol."},{"key":"10.1016\/j.neubiorev.2019.09.023_bib0285","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1542\/peds.103.4.730","article-title":"Stimulant medication withdrawal during long-term therapy in children with comorbid attention-deficit hyperactivity disorder and chronic multiple tic disorder","volume":"103","author":"Nolan","year":"1999","journal-title":"Pediatrics"},{"key":"10.1016\/j.neubiorev.2019.09.023_bib0290","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1089\/cap.1999.9.169","article-title":"Childhood inattention-overactivity, aggression, and stimulant medication history as predictors of young adult outcomes","volume":"9","author":"Paternite","year":"1999","journal-title":"J. Child Adolesc. Psychopharmacol."},{"key":"10.1016\/j.neubiorev.2019.09.023_bib0295","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1001\/jamapsychiatry.2015.2146","article-title":"Effects of Group Psychotherapy, Individual Counseling, Methylphenidate, and Placebo in the Treatment of Adult Attention-Deficit\/Hyperactivity Disorder: A Randomized Clinical Trial","volume":"72","author":"Philipsen","year":"2015","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.neubiorev.2019.09.023_bib0300","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1176\/ajp.132.3.241","article-title":"One-year follow-up of hyperactive boys treated with imipramine or methylphenidate","volume":"132","author":"Quinn","year":"1975","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neubiorev.2019.09.023_bib0305","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1097\/CHI.0b013e318067fd7c","article-title":"Methylphenidate and somatic hallucinations","volume":"46","author":"Rashid","year":"2007","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.neubiorev.2019.09.023_bib0310","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1089\/cap.1995.5.205","article-title":"Methylphenidate Discontinuation and Reinitiation during Long-Term Treatment of Children with Tourette\u2019s Disorder and Attention-Deficit Hyperactivity Disorder: A Pilot Study","volume":"5","author":"Riddle","year":"1995","journal-title":"J. Child Adolesc. Psychopharmacol."},{"key":"10.1016\/j.neubiorev.2019.09.023_bib0315","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1176\/ajp.136.2.226","article-title":"Depression and psychotic regression following prolonged methylphenidate use and withdrawal: case report","volume":"136","author":"Rosenfeld","year":"1979","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neubiorev.2019.09.023_bib0320","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.yebeh.2014.04.021","article-title":"Key issues in addressing the comorbidity of attention deficit hyperactivity disorder and pediatric epilepsy","volume":"37","author":"Salpekar","year":"2014","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.neubiorev.2019.09.023_bib0325","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1089\/cap.2007.0141","article-title":"Seizures induced by the combination treatment of methylphenidate and sertraline","volume":"18","author":"Schertz","year":"2008","journal-title":"J. Child Adolesc. Psychopharmacol."},{"key":"10.1016\/j.neubiorev.2019.09.023_bib0330","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1007\/s11682-017-9707-x","article-title":"Long-term effects of stimulant exposure on cerebral blood flow response to methylphenidate and behavior in attention-deficit hyperactivity disorder","volume":"12","author":"Schrantee","year":"2018","journal-title":"Brain Imaging Behav."},{"key":"10.1016\/j.neubiorev.2019.09.023_bib0335","first-page":"146","article-title":"The dual diagnosis of attention-deficit\/hyperactivity disorder and substance abuse: case reports and literature review","volume":"56","author":"Schubiner","year":"1995","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.neubiorev.2019.09.023_bib0340","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.schres.2015.08.033","article-title":"Attention-deficit\/hyperactivity disorder, methylphenidate use and the risk of developing schizophrenia spectrum disorders: a nationwide population-based study in Taiwan","volume":"168","author":"Shyu","year":"2015","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.neubiorev.2019.09.023_bib0345","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/j.sleep.2009.04.003","article-title":"Sleep disorders in children with Attention-Deficit\/Hyperactivity Disorder (ADHD) recorded overnight by video-polysomnography","volume":"10","author":"Silvestri","year":"2009","journal-title":"Sleep Med."},{"key":"10.1016\/j.neubiorev.2019.09.023_bib0350","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ebcr.2018.03.002","article-title":"Long-term use of methylphenidate in a boy with hypothalamic tumor, drug-resistant epilepsy and ADHD","volume":"10","author":"Socanski","year":"2018","journal-title":"Epilepsy Behav. Case Rep."},{"key":"10.1016\/j.neubiorev.2019.09.023_bib0355","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1089\/cap.1993.3.231","article-title":"Case report: four purported cases of methylphenidate-induced tic exacerbation: methodological and clinical doubts","volume":"3","author":"Sprafkin","year":"1993","journal-title":"J. Child Adolesc. Psychopharmacol."},{"key":"10.1016\/j.neubiorev.2019.09.023_bib0360","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.euroneuro.2013.11.003","article-title":"Substance use disorders in association with attention-deficit\/hyperactivity disorder, co-morbid mental disorders, and medication in a nationwide sample","volume":"24","author":"Steinhausen","year":"2014","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.neubiorev.2019.09.023_bib0365","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1097\/JCP.0b013e3182664dbc","article-title":"Predictive factors for more than 3 years\u2019 duration of central stimulant treatment in adult attention-deficit\/hyperactivity disorder: a retrospective, naturalistic study","volume":"32","author":"Torgersen","year":"2012","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.neubiorev.2019.09.023_bib0370","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1053\/comp.2001.23145","article-title":"Emergence of tics in children with attention deficit hyperactivity disorder treated with stimulant medications","volume":"42","author":"Varley","year":"2001","journal-title":"Compr. Psychiatry"},{"key":"10.1016\/j.neubiorev.2019.09.023_bib0375","first-page":"511","article-title":"Cyclic Alternating Pattern Associated with Catathrenia and Bruxism in a 10-Year-Old Patient","volume":"13","author":"Villafuerte-Trisolini","year":"2017","journal-title":"J. Clin. Sleep Med. JCSM Off. Publ. Am. Acad. Sleep Med."},{"key":"10.1016\/j.neubiorev.2019.09.023_bib0380","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.jpsychires.2015.10.014","article-title":"Attention-deficit hyperactivity disorder, its pharmacotherapy, and the risk of developing bipolar disorder: a nationwide population-based study in Taiwan.[Erratum appears in J Psychiatr Res. 2016 Apr;75:22]","volume":"72","author":"Wang","year":"2016","journal-title":"J. Psychiatr. Res."},{"issue":"8","key":"10.1016\/j.neubiorev.2019.09.023_bib0385","article-title":"Initiation and persistence of pharmacotherapy for youths with attention deficit hyperactivity disorder in Taiwan","volume":"11","author":"Wang","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.neubiorev.2019.09.023_bib0390","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1136\/jnnp.46.1.75","article-title":"Gilles de la Tourette\u2019s syndrome in monozygotic twins","volume":"46","author":"Waserman","year":"1983","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.neubiorev.2019.09.023_bib0395","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1212\/WNL.28.10.1041","article-title":"Methylphenidate-induced chorea: case report and pharmacologic implications","volume":"28","author":"Weiner","year":"1978","journal-title":"Neurology"},{"key":"10.1016\/j.neubiorev.2019.09.023_bib0400","first-page":"159","article-title":"Effect of long-term treatment of hyperactive children with methylphenidate","volume":"112","author":"Weiss","year":"1975","journal-title":"Can. Med. Assoc. J."},{"key":"10.1016\/j.neubiorev.2019.09.023_bib0405","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1097\/01.chi.0000173291.28688.e7","article-title":"ADHD treatment with once-daily OROS methylphenidate: final results from a long-term open-label study","volume":"44","author":"Wilens","year":"2005","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.neubiorev.2019.09.023_bib0410","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/00004703-198106000-00003","article-title":"Methylphenidate-induced hallucinosis: case histories and possible mechanisms of action","volume":"2","author":"Young","year":"1981","journal-title":"J. Dev. Behav. Pediatr."}],"container-title":["Neuroscience & Biobehavioral Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149763419302350?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149763419302350?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T09:56:08Z","timestamp":1758966968000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149763419302350"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":82,"alternative-id":["S0149763419302350"],"URL":"https:\/\/doi.org\/10.1016\/j.neubiorev.2019.09.023","relation":{},"ISSN":["0149-7634"],"issn-type":[{"value":"0149-7634","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neurological and psychiatric adverse effects of long-term methylphenidate treatment in ADHD: A map of the current evidence","name":"articletitle","label":"Article Title"},{"value":"Neuroscience & Biobehavioral Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neubiorev.2019.09.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}